Details for Patent: 7,795,293
✉ Email this page to a colleague
Summary for Patent: 7,795,293
Title: | 3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-y- lidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine) |
Abstract: | An improved thrombopoietin mimetic, the bis-(monoethanolamine) salt of 3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-- ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid. |
Inventor(s): | Moore; Stephen (Tonbridge, GB) |
Assignee: | GlaxoSmithKline LLC (Philadelphia, PA) |
Application Number: | 12/472,819 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 7,795,293 |
Patent Claim Types: see list of patent claims | Use; Delivery; |
Drugs Protected by US Patent 7,795,293
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,795,293
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 040083 | ⤷ Try a Trial | |||
Austria | 452683 | ⤷ Try a Trial | |||
Australia | 2003241587 | ⤷ Try a Trial | |||
Brazil | 0310094 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |